Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of March 2014. The report serves to disclose a specific corporate governance event rather than financial performance results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notification of management changes and does not contain financial statements or key performance indicators.
Material Changes
The primary material change disclosed is the announcement of Management Board Changes issued via an Investor News release on March 12, 2014. No financial variances compared to prior periods are reported in this text.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document strictly references the attached Investor News Release regarding the leadership transition.
Key Facts for Investors
- The Company announced changes to its Management Board on March 12, 2014.
- The report was signed by Rice Powell (CEO and Chairman) and Michael Brosnan (CFO).
- No financial data or operational metrics are included in this specific filing.
- Investors should refer to the attached Exhibit 99.1 for details on the specific personnel changes.